Eli Lilly insider Edgardo Hernandez files Form 4 reporting ownership change
Rhea-AI Filing Summary
Edgardo Hernandez, EVP & President, Manufacturing Operations at Eli Lilly & Co. (LLY), reported changes in ownership on a Form 4. On 09/05/2025 he disposed of 17 shares of Eli Lilly common stock in a transaction coded G at a price of $0. After the reported disposition he directly beneficially owned 39,731.435 shares and indirectly held 872.3 shares through a 401(k). No derivative securities were reported. The form was signed on behalf of Mr. Hernandez on 09/08/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Section 16 reporting of an insider disposition with direct and indirect holdings disclosed.
This Form 4 shows a single non-derivative disposition by an executive officer. The entry reports a transaction dated 09/05/2025 coded "G" for 17 shares at a reported price of $0, followed by disclosure of 39,731.435 shares directly owned and 872.3 shares held indirectly in a 401(k). There are no derivative positions reported. The filing appears administrative and complies with Section 16 reporting by identifying the reporting person, relationship to the issuer, transaction details, and signature authorization dated 09/08/2025.
TL;DR: Disclosure is concise and procedural; no material corporate governance changes are indicated.
The Form 4 provides required transparency about an insider transaction by an officer of LLY. It lists direct and indirect beneficial ownership and shows no new option grants or derivative activity. The presence of an authorized representative signature is noted. Based solely on the form's contents, this filing is a routine ownership update rather than a governance event.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 17 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |